Novel Lipid Formulations For Nucleic Acid Delivery

Patent No. EP2279254 (titled "Novel Lipid Formulations For Nucleic Acid Delivery") was filed by Arbutus Biopharma on Apr 15, 2009. The application was issued on Jul 5, 2017.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_617/2025Jul 9, 2025ModernaCounter Claim For Revocation
UPC_CFI_191/2025Mar 3, 2025Arbutus Biopharma, Genevant SciencesInfringement

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2279254

ARBUTUS BIOPHARMA
Application Number
EP09731866A
Filing Date
Apr 15, 2009
Status
Granted And Under Opposition
Jun 2, 2017
Publication Date
Jul 5, 2017